5 Conclusion In summary, the present study analyzed the molecular network of semaglutide to improve the hepatic outcome of T2DM-MAFLD at a multi-omics level, and revealed the innovative mechanism of its therapeutic effects through the metabolic-inflammatory-mitochondrial axis
acknowledges support from the NIH (R35GM119512)
60 However, in humans, early studies demonstrated that GLP-2 administration for five weeks increased spinal BMD in people with short bowel syndrome, 62 but had limited overall bone benefits
EFFECTIVE CardioDefence contributes to normal cysteine synthesis, homocysteine metabolism, protein and glycogen metabolism, red blood cell formation and contributes to the normal function of the immune system
More than 53 different fumonisins have been reported so far (Marasas, 1995